In the United States, the battle against cervical cancer is ongoing, with about 11,500 new cases and approximately 4,000 deaths annually. These figures underscore the importance of awareness, early detection, and prevention. With January being Cervical Cancer Awareness Month, it’s a pertinent time to highlight not only the risks but also the powerful preventive measures available, such as the Gardasil 9 vaccine.
Understanding HPV and Cervical Cancer
Cervical cancer is primarily caused by specific strains of the Human Papillomavirus (HPV), with types 16 and 18 approximately accounting for more than 90% of cases. HPV is a common sexually transmitted infection with hundreds of different strains. It is often asymptomatic, which makes regular screenings essential for early detection and prevention.
Risk Factors for Cervical Cancer
Several factors increase the risk of developing cervical cancer, including:
- Persistent HPV infection.
- Smoking.
- Long-term use of oral contraceptives.
- Weakened immune system.
- Engaging in sexual activity at an early age and multiple sexual partners.
- Being aware of these factors can guide individuals in making informed health decisions.
Screening: Pap Smear and HPV Testing
Regular screening is key in detecting cervical cancer in its early stages. Pap smears are recommended for women starting at age 21, with HPV testing added for those over 30. The image to the left visually demonstrates the differences between a healthy cervix and one affected by cancerous changes. This is why it is so important to educate and encourage women to participate in regular screenings because these tests help identify precancerous changes in the cervix, allowing for early detection or timely intervention.
The Gardasil Vaccine: A Game-Changer in Prevention
The Gardasil vaccine represents a significant breakthrough in cancer prevention. The new vaccine, Gardasil 9, protects you against 9 types of HPV. There are hundreds of types of HPV however the low risk (6,11) protect against genital warts. High risk (16,18,31,33,45,52,58) protect you against precancerous and cancers of the cervix, vulva, vagina, anus and certain head and neck areas.
The vaccine is >99% effective for 6,11,18 and 18. It is greater than 96% for types 31, 33, 45, 52, and 58. The CDC recommends the Gardasil vaccine for both boys and girls, ideally administered at ages 11/12 and up to 45. The earlier given the more effective the vaccine due to lower exposer. We need to increase the vaccination rates as they are low in the United States. The CDC recommends the Gardasil vaccine for both boys and girls, ideally administered at ages 11 or 12, though it can be given up to age 45. The vaccine not only reduces the risk of cervical cancer but also other HPV-related cancers.
Focus on Prevention and Awareness
Vaccination with Gardasil, combined with regular screenings, offers the best defense against cervical cancer. Spreading awareness about the Gardasil vaccine and its benefits is crucial. During Cervical Health Awareness Month, we can use platforms like social media, community events, and educational programs to promote this message.
Cervical Health Awareness Month is an opportunity to reinforce the message that cervical cancer is preventable. By incorporating preventive measures like the Gardasil vaccine and regular screenings, we can significantly reduce the incidence of this disease. Let’s encourage discussions, share information, and consult healthcare professionals to make informed decisions. Together, we can aim for a future where cervical cancer becomes a rare diagnosis, saving countless lives in the process.
